nodes	percent_of_prediction	percent_of_DWPC	metapath
Methyldopa—SLC15A1—epithelium—stomach cancer	0.00645	0.084	CbGeAlD
Methyldopa—COMT—hematopoietic system—stomach cancer	0.00627	0.0817	CbGeAlD
Methyldopa—Aminosalicylic Acid—ALOX5—stomach cancer	0.00578	0.13	CrCbGaD
Methyldopa—Isoprenaline—MAPK1—stomach cancer	0.00558	0.126	CrCbGaD
Methyldopa—COMT—smooth muscle tissue—stomach cancer	0.00552	0.072	CbGeAlD
Methyldopa—DDC—endocrine gland—stomach cancer	0.00545	0.071	CbGeAlD
Methyldopa—COMT—pancreas—stomach cancer	0.00511	0.0666	CbGeAlD
Methyldopa—DDC—liver—stomach cancer	0.00491	0.064	CbGeAlD
Methyldopa—SLC15A1—digestive system—stomach cancer	0.0049	0.0639	CbGeAlD
Methyldopa—Mesalazine—ALOX5—stomach cancer	0.00453	0.102	CrCbGaD
Methyldopa—COMT—digestive system—stomach cancer	0.00436	0.0568	CbGeAlD
Methyldopa—SLC15A1—endocrine gland—stomach cancer	0.00405	0.0528	CbGeAlD
Methyldopa—COMT—bone marrow—stomach cancer	0.00402	0.0524	CbGeAlD
Methyldopa—Isoetarine—ADRB1—stomach cancer	0.00401	0.0906	CrCbGaD
Methyldopa—DDC—lymph node—stomach cancer	0.00377	0.0491	CbGeAlD
Methyldopa—SLC15A1—liver—stomach cancer	0.00365	0.0476	CbGeAlD
Methyldopa—COMT—endocrine gland—stomach cancer	0.0036	0.047	CbGeAlD
Methyldopa—Isoetarine—ADRB2—stomach cancer	0.00337	0.0762	CrCbGaD
Methyldopa—COMT—liver—stomach cancer	0.00325	0.0423	CbGeAlD
Methyldopa—ADRA2A—hematopoietic system—stomach cancer	0.00319	0.0416	CbGeAlD
Methyldopa—ADRA2A—pancreas—stomach cancer	0.0026	0.0339	CbGeAlD
Methyldopa—Mesalazine—PPARG—stomach cancer	0.00259	0.0586	CrCbGaD
Methyldopa—COMT—lymph node—stomach cancer	0.00249	0.0325	CbGeAlD
Methyldopa—Toxic epidermal necrolysis—Capecitabine—stomach cancer	0.0023	0.00332	CcSEcCtD
Methyldopa—Hepatocellular injury—Doxorubicin—stomach cancer	0.00227	0.00328	CcSEcCtD
Methyldopa—Flatulence—Irinotecan—stomach cancer	0.00227	0.00327	CcSEcCtD
Methyldopa—Abdominal distension—Capecitabine—stomach cancer	0.00222	0.00321	CcSEcCtD
Methyldopa—Angina pectoris—Docetaxel—stomach cancer	0.00222	0.00321	CcSEcCtD
Methyldopa—Colitis—Doxorubicin—stomach cancer	0.00218	0.00315	CcSEcCtD
Methyldopa—Pancytopenia—Docetaxel—stomach cancer	0.00217	0.00313	CcSEcCtD
Methyldopa—Angina pectoris—Capecitabine—stomach cancer	0.00215	0.00311	CcSEcCtD
Methyldopa—Pancytopenia—Capecitabine—stomach cancer	0.0021	0.00303	CcSEcCtD
Methyldopa—Weight increased—Docetaxel—stomach cancer	0.00208	0.003	CcSEcCtD
Methyldopa—Leukopenia—Irinotecan—stomach cancer	0.00206	0.00297	CcSEcCtD
Methyldopa—Infestation—Docetaxel—stomach cancer	0.00204	0.00294	CcSEcCtD
Methyldopa—Infestation NOS—Docetaxel—stomach cancer	0.00204	0.00294	CcSEcCtD
Methyldopa—Weight increased—Capecitabine—stomach cancer	0.00201	0.0029	CcSEcCtD
Methyldopa—Jaundice—Docetaxel—stomach cancer	0.00198	0.00286	CcSEcCtD
Methyldopa—Eczema—Epirubicin—stomach cancer	0.00198	0.00286	CcSEcCtD
Methyldopa—Leukopenia—Fluorouracil—stomach cancer	0.00197	0.00285	CcSEcCtD
Methyldopa—Infestation NOS—Capecitabine—stomach cancer	0.00197	0.00285	CcSEcCtD
Methyldopa—Infestation—Capecitabine—stomach cancer	0.00197	0.00285	CcSEcCtD
Methyldopa—Cardiac failure congestive—Epirubicin—stomach cancer	0.00196	0.00284	CcSEcCtD
Methyldopa—Hepatobiliary disease—Docetaxel—stomach cancer	0.00192	0.00278	CcSEcCtD
Methyldopa—Jaundice—Capecitabine—stomach cancer	0.00192	0.00277	CcSEcCtD
Methyldopa—Agranulocytosis—Docetaxel—stomach cancer	0.0019	0.00274	CcSEcCtD
Methyldopa—Oedema—Irinotecan—stomach cancer	0.00188	0.00271	CcSEcCtD
Methyldopa—Myalgia—Fluorouracil—stomach cancer	0.00188	0.00271	CcSEcCtD
Methyldopa—Infection—Irinotecan—stomach cancer	0.00187	0.00269	CcSEcCtD
Methyldopa—Hepatobiliary disease—Capecitabine—stomach cancer	0.00186	0.00269	CcSEcCtD
Methyldopa—Nervous system disorder—Irinotecan—stomach cancer	0.00184	0.00266	CcSEcCtD
Methyldopa—Agranulocytosis—Capecitabine—stomach cancer	0.00184	0.00266	CcSEcCtD
Methyldopa—Thrombocytopenia—Irinotecan—stomach cancer	0.00184	0.00265	CcSEcCtD
Methyldopa—ADRA2A—endocrine gland—stomach cancer	0.00184	0.0239	CbGeAlD
Methyldopa—Eczema—Doxorubicin—stomach cancer	0.00183	0.00265	CcSEcCtD
Methyldopa—Droxidopa—ADRB1—stomach cancer	0.00183	0.0414	CrCbGaD
Methyldopa—Hepatitis—Docetaxel—stomach cancer	0.00183	0.00264	CcSEcCtD
Methyldopa—Cardiac failure congestive—Doxorubicin—stomach cancer	0.00182	0.00262	CcSEcCtD
Methyldopa—Bradycardia—Capecitabine—stomach cancer	0.0018	0.0026	CcSEcCtD
Methyldopa—Oedema—Fluorouracil—stomach cancer	0.0018	0.0026	CcSEcCtD
Methyldopa—Connective tissue disorder—Docetaxel—stomach cancer	0.0018	0.00259	CcSEcCtD
Methyldopa—Infection—Fluorouracil—stomach cancer	0.00179	0.00258	CcSEcCtD
Methyldopa—Hepatitis—Capecitabine—stomach cancer	0.00177	0.00255	CcSEcCtD
Methyldopa—Nervous system disorder—Fluorouracil—stomach cancer	0.00176	0.00255	CcSEcCtD
Methyldopa—Thrombocytopenia—Fluorouracil—stomach cancer	0.00176	0.00254	CcSEcCtD
Methyldopa—Liver function test abnormal—Methotrexate—stomach cancer	0.00176	0.00254	CcSEcCtD
Methyldopa—Connective tissue disorder—Capecitabine—stomach cancer	0.00174	0.00251	CcSEcCtD
Methyldopa—Breast disorder—Methotrexate—stomach cancer	0.00172	0.00248	CcSEcCtD
Methyldopa—Toxic epidermal necrolysis—Methotrexate—stomach cancer	0.00171	0.00248	CcSEcCtD
Methyldopa—Cardiac disorder—Docetaxel—stomach cancer	0.0017	0.00245	CcSEcCtD
Methyldopa—Paraesthesia—Irinotecan—stomach cancer	0.00169	0.00243	CcSEcCtD
Methyldopa—Isoprenaline—ADRB1—stomach cancer	0.00166	0.0376	CrCbGaD
Methyldopa—Angiopathy—Docetaxel—stomach cancer	0.00166	0.00239	CcSEcCtD
Methyldopa—Mediastinal disorder—Docetaxel—stomach cancer	0.00165	0.00238	CcSEcCtD
Methyldopa—Liver function test abnormal—Epirubicin—stomach cancer	0.00164	0.00237	CcSEcCtD
Methyldopa—Cardiac disorder—Capecitabine—stomach cancer	0.00164	0.00237	CcSEcCtD
Methyldopa—Musculoskeletal discomfort—Fluorouracil—stomach cancer	0.00164	0.00237	CcSEcCtD
Methyldopa—Eosinophilia—Methotrexate—stomach cancer	0.00163	0.00235	CcSEcCtD
Methyldopa—Orthostatic hypotension—Epirubicin—stomach cancer	0.00163	0.00235	CcSEcCtD
Methyldopa—Gastrointestinal disorder—Irinotecan—stomach cancer	0.00162	0.00234	CcSEcCtD
Methyldopa—Paraesthesia—Fluorouracil—stomach cancer	0.00161	0.00233	CcSEcCtD
Methyldopa—Pancreatitis—Methotrexate—stomach cancer	0.00161	0.00233	CcSEcCtD
Methyldopa—Breast disorder—Epirubicin—stomach cancer	0.00161	0.00232	CcSEcCtD
Methyldopa—Constipation—Irinotecan—stomach cancer	0.00161	0.00232	CcSEcCtD
Methyldopa—Angiopathy—Capecitabine—stomach cancer	0.0016	0.00232	CcSEcCtD
Methyldopa—Toxic epidermal necrolysis—Epirubicin—stomach cancer	0.0016	0.00232	CcSEcCtD
Methyldopa—Mental disorder—Docetaxel—stomach cancer	0.0016	0.00231	CcSEcCtD
Methyldopa—Mediastinal disorder—Capecitabine—stomach cancer	0.00159	0.0023	CcSEcCtD
Methyldopa—Pancytopenia—Methotrexate—stomach cancer	0.00156	0.00226	CcSEcCtD
Methyldopa—Gastrointestinal disorder—Fluorouracil—stomach cancer	0.00155	0.00224	CcSEcCtD
Methyldopa—Abdominal distension—Epirubicin—stomach cancer	0.00155	0.00224	CcSEcCtD
Methyldopa—Mental disorder—Capecitabine—stomach cancer	0.00155	0.00224	CcSEcCtD
Methyldopa—Norepinephrine—ADRB1—stomach cancer	0.00154	0.0348	CrCbGaD
Methyldopa—Droxidopa—ADRB2—stomach cancer	0.00154	0.0348	CrCbGaD
Methyldopa—Eosinophilia—Epirubicin—stomach cancer	0.00152	0.0022	CcSEcCtD
Methyldopa—Liver function test abnormal—Doxorubicin—stomach cancer	0.00152	0.0022	CcSEcCtD
Methyldopa—Flatulence—Capecitabine—stomach cancer	0.00152	0.00219	CcSEcCtD
Methyldopa—Erectile dysfunction—Methotrexate—stomach cancer	0.00152	0.00219	CcSEcCtD
Methyldopa—Pancreatitis—Epirubicin—stomach cancer	0.00151	0.00218	CcSEcCtD
Methyldopa—Orthostatic hypotension—Doxorubicin—stomach cancer	0.00151	0.00217	CcSEcCtD
Methyldopa—Angina pectoris—Epirubicin—stomach cancer	0.0015	0.00217	CcSEcCtD
Methyldopa—Breast disorder—Doxorubicin—stomach cancer	0.00149	0.00215	CcSEcCtD
Methyldopa—Body temperature increased—Irinotecan—stomach cancer	0.00148	0.00214	CcSEcCtD
Methyldopa—Toxic epidermal necrolysis—Doxorubicin—stomach cancer	0.00148	0.00214	CcSEcCtD
Methyldopa—Infestation NOS—Methotrexate—stomach cancer	0.00147	0.00212	CcSEcCtD
Methyldopa—Infestation—Methotrexate—stomach cancer	0.00147	0.00212	CcSEcCtD
Methyldopa—Pancytopenia—Epirubicin—stomach cancer	0.00146	0.00211	CcSEcCtD
Methyldopa—Abdominal distension—Doxorubicin—stomach cancer	0.00143	0.00207	CcSEcCtD
Methyldopa—Dopamine—ADRB1—stomach cancer	0.00143	0.0324	CrCbGaD
Methyldopa—Leukopenia—Docetaxel—stomach cancer	0.00142	0.00206	CcSEcCtD
Methyldopa—Body temperature increased—Fluorouracil—stomach cancer	0.00142	0.00205	CcSEcCtD
Methyldopa—Eosinophilia—Doxorubicin—stomach cancer	0.00141	0.00204	CcSEcCtD
Methyldopa—Weight increased—Epirubicin—stomach cancer	0.0014	0.00202	CcSEcCtD
Methyldopa—Isoprenaline—ADRB2—stomach cancer	0.0014	0.0316	CrCbGaD
Methyldopa—Epinephrine—ADRB1—stomach cancer	0.0014	0.0316	CrCbGaD
Methyldopa—Pancreatitis—Doxorubicin—stomach cancer	0.0014	0.00202	CcSEcCtD
Methyldopa—Aminosalicylic Acid—PTGS2—stomach cancer	0.0014	0.0315	CrCbGaD
Methyldopa—Angina pectoris—Doxorubicin—stomach cancer	0.00139	0.002	CcSEcCtD
Methyldopa—Hepatobiliary disease—Methotrexate—stomach cancer	0.00139	0.002	CcSEcCtD
Methyldopa—Hypersensitivity—Irinotecan—stomach cancer	0.00138	0.002	CcSEcCtD
Methyldopa—Leukopenia—Capecitabine—stomach cancer	0.00138	0.00199	CcSEcCtD
Methyldopa—Infestation NOS—Epirubicin—stomach cancer	0.00137	0.00198	CcSEcCtD
Methyldopa—Infestation—Epirubicin—stomach cancer	0.00137	0.00198	CcSEcCtD
Methyldopa—Agranulocytosis—Methotrexate—stomach cancer	0.00137	0.00198	CcSEcCtD
Methyldopa—Arthralgia—Docetaxel—stomach cancer	0.00135	0.00196	CcSEcCtD
Methyldopa—Myalgia—Docetaxel—stomach cancer	0.00135	0.00196	CcSEcCtD
Methyldopa—Pancytopenia—Doxorubicin—stomach cancer	0.00135	0.00195	CcSEcCtD
Methyldopa—Asthenia—Irinotecan—stomach cancer	0.00135	0.00195	CcSEcCtD
Methyldopa—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—stomach cancer	0.00134	0.00194	CcSEcCtD
Methyldopa—Jaundice—Epirubicin—stomach cancer	0.00134	0.00193	CcSEcCtD
Methyldopa—Epinephrine—TNF—stomach cancer	0.00133	0.03	CrCbGaD
Methyldopa—Hypersensitivity—Fluorouracil—stomach cancer	0.00132	0.00191	CcSEcCtD
Methyldopa—Hepatitis—Methotrexate—stomach cancer	0.00132	0.0019	CcSEcCtD
Methyldopa—Myalgia—Capecitabine—stomach cancer	0.00131	0.00189	CcSEcCtD
Methyldopa—Arthralgia—Capecitabine—stomach cancer	0.00131	0.00189	CcSEcCtD
Methyldopa—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—stomach cancer	0.0013	0.00188	CcSEcCtD
Methyldopa—Hepatobiliary disease—Epirubicin—stomach cancer	0.0013	0.00187	CcSEcCtD
Methyldopa—Oedema—Docetaxel—stomach cancer	0.0013	0.00187	CcSEcCtD
Methyldopa—Norepinephrine—ADRB2—stomach cancer	0.0013	0.0293	CrCbGaD
Methyldopa—Weight increased—Doxorubicin—stomach cancer	0.0013	0.00187	CcSEcCtD
Methyldopa—Infection—Docetaxel—stomach cancer	0.00129	0.00186	CcSEcCtD
Methyldopa—Diarrhoea—Irinotecan—stomach cancer	0.00128	0.00186	CcSEcCtD
Methyldopa—Dopamine—HTR1A—stomach cancer	0.00128	0.029	CrCbGaD
Methyldopa—Agranulocytosis—Epirubicin—stomach cancer	0.00128	0.00185	CcSEcCtD
Methyldopa—Nervous system disorder—Docetaxel—stomach cancer	0.00127	0.00184	CcSEcCtD
Methyldopa—Thrombocytopenia—Docetaxel—stomach cancer	0.00127	0.00184	CcSEcCtD
Methyldopa—Infestation NOS—Doxorubicin—stomach cancer	0.00127	0.00183	CcSEcCtD
Methyldopa—Infestation—Doxorubicin—stomach cancer	0.00127	0.00183	CcSEcCtD
Methyldopa—ADRA2A—lymph node—stomach cancer	0.00127	0.0165	CbGeAlD
Methyldopa—Skin disorder—Docetaxel—stomach cancer	0.00126	0.00182	CcSEcCtD
Methyldopa—Oedema—Capecitabine—stomach cancer	0.00126	0.00181	CcSEcCtD
Methyldopa—Bradycardia—Epirubicin—stomach cancer	0.00125	0.00181	CcSEcCtD
Methyldopa—Infection—Capecitabine—stomach cancer	0.00125	0.0018	CcSEcCtD
Methyldopa—Dizziness—Irinotecan—stomach cancer	0.00124	0.00179	CcSEcCtD
Methyldopa—Jaundice—Doxorubicin—stomach cancer	0.00124	0.00179	CcSEcCtD
Methyldopa—Nervous system disorder—Capecitabine—stomach cancer	0.00123	0.00178	CcSEcCtD
Methyldopa—Hepatitis—Epirubicin—stomach cancer	0.00123	0.00178	CcSEcCtD
Methyldopa—Diarrhoea—Fluorouracil—stomach cancer	0.00123	0.00178	CcSEcCtD
Methyldopa—Thrombocytopenia—Capecitabine—stomach cancer	0.00123	0.00178	CcSEcCtD
Methyldopa—Cardiac disorder—Methotrexate—stomach cancer	0.00122	0.00176	CcSEcCtD
Methyldopa—Skin disorder—Capecitabine—stomach cancer	0.00122	0.00176	CcSEcCtD
Methyldopa—Connective tissue disorder—Epirubicin—stomach cancer	0.00121	0.00175	CcSEcCtD
Methyldopa—Hepatobiliary disease—Doxorubicin—stomach cancer	0.0012	0.00173	CcSEcCtD
Methyldopa—Angiopathy—Methotrexate—stomach cancer	0.00119	0.00173	CcSEcCtD
Methyldopa—Vomiting—Irinotecan—stomach cancer	0.00119	0.00172	CcSEcCtD
Methyldopa—Dizziness—Fluorouracil—stomach cancer	0.00119	0.00172	CcSEcCtD
Methyldopa—Mediastinal disorder—Methotrexate—stomach cancer	0.00119	0.00171	CcSEcCtD
Methyldopa—Agranulocytosis—Doxorubicin—stomach cancer	0.00119	0.00171	CcSEcCtD
Methyldopa—Rash—Irinotecan—stomach cancer	0.00118	0.00171	CcSEcCtD
Methyldopa—Dermatitis—Irinotecan—stomach cancer	0.00118	0.00171	CcSEcCtD
Methyldopa—Musculoskeletal discomfort—Docetaxel—stomach cancer	0.00118	0.00171	CcSEcCtD
Methyldopa—Epinephrine—ADRB2—stomach cancer	0.00118	0.0266	CrCbGaD
Methyldopa—Headache—Irinotecan—stomach cancer	0.00118	0.0017	CcSEcCtD
Methyldopa—Paraesthesia—Docetaxel—stomach cancer	0.00117	0.00168	CcSEcCtD
Methyldopa—Bradycardia—Doxorubicin—stomach cancer	0.00116	0.00168	CcSEcCtD
Methyldopa—Mental disorder—Methotrexate—stomach cancer	0.00115	0.00167	CcSEcCtD
Methyldopa—Musculoskeletal discomfort—Capecitabine—stomach cancer	0.00114	0.00165	CcSEcCtD
Methyldopa—Cardiac disorder—Epirubicin—stomach cancer	0.00114	0.00165	CcSEcCtD
Methyldopa—Vomiting—Fluorouracil—stomach cancer	0.00114	0.00165	CcSEcCtD
Methyldopa—Hepatitis—Doxorubicin—stomach cancer	0.00114	0.00165	CcSEcCtD
Methyldopa—Rash—Fluorouracil—stomach cancer	0.00113	0.00164	CcSEcCtD
Methyldopa—Dermatitis—Fluorouracil—stomach cancer	0.00113	0.00164	CcSEcCtD
Methyldopa—Paraesthesia—Capecitabine—stomach cancer	0.00113	0.00163	CcSEcCtD
Methyldopa—Headache—Fluorouracil—stomach cancer	0.00113	0.00163	CcSEcCtD
Methyldopa—Gastrointestinal disorder—Docetaxel—stomach cancer	0.00112	0.00162	CcSEcCtD
Methyldopa—Connective tissue disorder—Doxorubicin—stomach cancer	0.00112	0.00162	CcSEcCtD
Methyldopa—Angiopathy—Epirubicin—stomach cancer	0.00112	0.00161	CcSEcCtD
Methyldopa—Nausea—Irinotecan—stomach cancer	0.00112	0.00161	CcSEcCtD
Methyldopa—Mediastinal disorder—Epirubicin—stomach cancer	0.00111	0.0016	CcSEcCtD
Methyldopa—Constipation—Docetaxel—stomach cancer	0.00111	0.0016	CcSEcCtD
Methyldopa—Mesalazine—PTGS2—stomach cancer	0.00109	0.0247	CrCbGaD
Methyldopa—Gastrointestinal disorder—Capecitabine—stomach cancer	0.00108	0.00157	CcSEcCtD
Methyldopa—Mental disorder—Epirubicin—stomach cancer	0.00108	0.00156	CcSEcCtD
Methyldopa—Constipation—Capecitabine—stomach cancer	0.00107	0.00155	CcSEcCtD
Methyldopa—Nausea—Fluorouracil—stomach cancer	0.00107	0.00154	CcSEcCtD
Methyldopa—Cardiac disorder—Doxorubicin—stomach cancer	0.00106	0.00153	CcSEcCtD
Methyldopa—Flatulence—Epirubicin—stomach cancer	0.00106	0.00153	CcSEcCtD
Methyldopa—Angiopathy—Doxorubicin—stomach cancer	0.00103	0.00149	CcSEcCtD
Methyldopa—Mediastinal disorder—Doxorubicin—stomach cancer	0.00103	0.00148	CcSEcCtD
Methyldopa—Body temperature increased—Docetaxel—stomach cancer	0.00103	0.00148	CcSEcCtD
Methyldopa—Leukopenia—Methotrexate—stomach cancer	0.00103	0.00148	CcSEcCtD
Methyldopa—Mental disorder—Doxorubicin—stomach cancer	0.000999	0.00144	CcSEcCtD
Methyldopa—Body temperature increased—Capecitabine—stomach cancer	0.000993	0.00143	CcSEcCtD
Methyldopa—Flatulence—Doxorubicin—stomach cancer	0.000978	0.00141	CcSEcCtD
Methyldopa—Arthralgia—Methotrexate—stomach cancer	0.000976	0.00141	CcSEcCtD
Methyldopa—Myalgia—Methotrexate—stomach cancer	0.000976	0.00141	CcSEcCtD
Methyldopa—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—stomach cancer	0.000969	0.0014	CcSEcCtD
Methyldopa—Leukopenia—Epirubicin—stomach cancer	0.00096	0.00139	CcSEcCtD
Methyldopa—Hypersensitivity—Docetaxel—stomach cancer	0.000956	0.00138	CcSEcCtD
Methyldopa—Asthenia—Docetaxel—stomach cancer	0.000931	0.00134	CcSEcCtD
Methyldopa—Infection—Methotrexate—stomach cancer	0.000929	0.00134	CcSEcCtD
Methyldopa—Hypersensitivity—Capecitabine—stomach cancer	0.000926	0.00134	CcSEcCtD
Methyldopa—Nervous system disorder—Methotrexate—stomach cancer	0.000917	0.00132	CcSEcCtD
Methyldopa—Thrombocytopenia—Methotrexate—stomach cancer	0.000916	0.00132	CcSEcCtD
Methyldopa—Myalgia—Epirubicin—stomach cancer	0.000913	0.00132	CcSEcCtD
Methyldopa—Arthralgia—Epirubicin—stomach cancer	0.000913	0.00132	CcSEcCtD
Methyldopa—Skin disorder—Methotrexate—stomach cancer	0.000909	0.00131	CcSEcCtD
Methyldopa—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—stomach cancer	0.000907	0.00131	CcSEcCtD
Methyldopa—Asthenia—Capecitabine—stomach cancer	0.000902	0.0013	CcSEcCtD
Methyldopa—Leukopenia—Doxorubicin—stomach cancer	0.000888	0.00128	CcSEcCtD
Methyldopa—Diarrhoea—Docetaxel—stomach cancer	0.000888	0.00128	CcSEcCtD
Methyldopa—Oedema—Epirubicin—stomach cancer	0.000875	0.00126	CcSEcCtD
Methyldopa—Infection—Epirubicin—stomach cancer	0.00087	0.00126	CcSEcCtD
Methyldopa—Diarrhoea—Capecitabine—stomach cancer	0.00086	0.00124	CcSEcCtD
Methyldopa—Nervous system disorder—Epirubicin—stomach cancer	0.000859	0.00124	CcSEcCtD
Methyldopa—Dizziness—Docetaxel—stomach cancer	0.000858	0.00124	CcSEcCtD
Methyldopa—Thrombocytopenia—Epirubicin—stomach cancer	0.000857	0.00124	CcSEcCtD
Methyldopa—Musculoskeletal discomfort—Methotrexate—stomach cancer	0.000852	0.00123	CcSEcCtD
Methyldopa—Skin disorder—Epirubicin—stomach cancer	0.00085	0.00123	CcSEcCtD
Methyldopa—Myalgia—Doxorubicin—stomach cancer	0.000845	0.00122	CcSEcCtD
Methyldopa—Arthralgia—Doxorubicin—stomach cancer	0.000845	0.00122	CcSEcCtD
Methyldopa—Paraesthesia—Methotrexate—stomach cancer	0.00084	0.00121	CcSEcCtD
Methyldopa—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—stomach cancer	0.000839	0.00121	CcSEcCtD
Methyldopa—Dizziness—Capecitabine—stomach cancer	0.000831	0.0012	CcSEcCtD
Methyldopa—Vomiting—Docetaxel—stomach cancer	0.000825	0.00119	CcSEcCtD
Methyldopa—Rash—Docetaxel—stomach cancer	0.000818	0.00118	CcSEcCtD
Methyldopa—Dermatitis—Docetaxel—stomach cancer	0.000818	0.00118	CcSEcCtD
Methyldopa—Headache—Docetaxel—stomach cancer	0.000813	0.00117	CcSEcCtD
Methyldopa—Oedema—Doxorubicin—stomach cancer	0.00081	0.00117	CcSEcCtD
Methyldopa—Gastrointestinal disorder—Methotrexate—stomach cancer	0.000808	0.00117	CcSEcCtD
Methyldopa—Infection—Doxorubicin—stomach cancer	0.000805	0.00116	CcSEcCtD
Methyldopa—Vomiting—Capecitabine—stomach cancer	0.000799	0.00115	CcSEcCtD
Methyldopa—Musculoskeletal discomfort—Epirubicin—stomach cancer	0.000798	0.00115	CcSEcCtD
Methyldopa—Nervous system disorder—Doxorubicin—stomach cancer	0.000794	0.00115	CcSEcCtD
Methyldopa—Thrombocytopenia—Doxorubicin—stomach cancer	0.000793	0.00115	CcSEcCtD
Methyldopa—Rash—Capecitabine—stomach cancer	0.000792	0.00114	CcSEcCtD
Methyldopa—Dermatitis—Capecitabine—stomach cancer	0.000792	0.00114	CcSEcCtD
Methyldopa—Headache—Capecitabine—stomach cancer	0.000787	0.00114	CcSEcCtD
Methyldopa—Skin disorder—Doxorubicin—stomach cancer	0.000787	0.00114	CcSEcCtD
Methyldopa—Paraesthesia—Epirubicin—stomach cancer	0.000786	0.00114	CcSEcCtD
Methyldopa—Nausea—Docetaxel—stomach cancer	0.000771	0.00111	CcSEcCtD
Methyldopa—Gastrointestinal disorder—Epirubicin—stomach cancer	0.000756	0.00109	CcSEcCtD
Methyldopa—Constipation—Epirubicin—stomach cancer	0.000749	0.00108	CcSEcCtD
Methyldopa—Nausea—Capecitabine—stomach cancer	0.000746	0.00108	CcSEcCtD
Methyldopa—Body temperature increased—Methotrexate—stomach cancer	0.000739	0.00107	CcSEcCtD
Methyldopa—Musculoskeletal discomfort—Doxorubicin—stomach cancer	0.000738	0.00107	CcSEcCtD
Methyldopa—Paraesthesia—Doxorubicin—stomach cancer	0.000727	0.00105	CcSEcCtD
Methyldopa—Gastrointestinal disorder—Doxorubicin—stomach cancer	0.000699	0.00101	CcSEcCtD
Methyldopa—Constipation—Doxorubicin—stomach cancer	0.000693	0.001	CcSEcCtD
Methyldopa—Body temperature increased—Epirubicin—stomach cancer	0.000692	0.000999	CcSEcCtD
Methyldopa—Hypersensitivity—Methotrexate—stomach cancer	0.000689	0.000995	CcSEcCtD
Methyldopa—Asthenia—Methotrexate—stomach cancer	0.000671	0.000969	CcSEcCtD
Methyldopa—Hypersensitivity—Epirubicin—stomach cancer	0.000645	0.000931	CcSEcCtD
Methyldopa—Body temperature increased—Doxorubicin—stomach cancer	0.00064	0.000925	CcSEcCtD
Methyldopa—Diarrhoea—Methotrexate—stomach cancer	0.00064	0.000924	CcSEcCtD
Methyldopa—Asthenia—Epirubicin—stomach cancer	0.000628	0.000907	CcSEcCtD
Methyldopa—Dizziness—Methotrexate—stomach cancer	0.000619	0.000893	CcSEcCtD
Methyldopa—Diarrhoea—Epirubicin—stomach cancer	0.000599	0.000865	CcSEcCtD
Methyldopa—Hypersensitivity—Doxorubicin—stomach cancer	0.000597	0.000862	CcSEcCtD
Methyldopa—Vomiting—Methotrexate—stomach cancer	0.000595	0.000859	CcSEcCtD
Methyldopa—Rash—Methotrexate—stomach cancer	0.00059	0.000852	CcSEcCtD
Methyldopa—Dermatitis—Methotrexate—stomach cancer	0.000589	0.000851	CcSEcCtD
Methyldopa—Headache—Methotrexate—stomach cancer	0.000586	0.000846	CcSEcCtD
Methyldopa—Asthenia—Doxorubicin—stomach cancer	0.000581	0.000839	CcSEcCtD
Methyldopa—Dizziness—Epirubicin—stomach cancer	0.000579	0.000836	CcSEcCtD
Methyldopa—Vomiting—Epirubicin—stomach cancer	0.000557	0.000804	CcSEcCtD
Methyldopa—Nausea—Methotrexate—stomach cancer	0.000556	0.000802	CcSEcCtD
Methyldopa—Diarrhoea—Doxorubicin—stomach cancer	0.000554	0.0008	CcSEcCtD
Methyldopa—Rash—Epirubicin—stomach cancer	0.000552	0.000797	CcSEcCtD
Methyldopa—Dermatitis—Epirubicin—stomach cancer	0.000551	0.000796	CcSEcCtD
Methyldopa—Headache—Epirubicin—stomach cancer	0.000548	0.000792	CcSEcCtD
Methyldopa—Dizziness—Doxorubicin—stomach cancer	0.000536	0.000774	CcSEcCtD
Methyldopa—Nausea—Epirubicin—stomach cancer	0.00052	0.000751	CcSEcCtD
Methyldopa—Vomiting—Doxorubicin—stomach cancer	0.000515	0.000744	CcSEcCtD
Methyldopa—Rash—Doxorubicin—stomach cancer	0.000511	0.000738	CcSEcCtD
Methyldopa—Dermatitis—Doxorubicin—stomach cancer	0.00051	0.000737	CcSEcCtD
Methyldopa—Headache—Doxorubicin—stomach cancer	0.000507	0.000733	CcSEcCtD
Methyldopa—Nausea—Doxorubicin—stomach cancer	0.000481	0.000695	CcSEcCtD
Methyldopa—DDC—Metabolism—ALDOB—stomach cancer	0.000302	0.00162	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—ACAD8—stomach cancer	0.0003	0.00161	CbGpPWpGaD
Methyldopa—ADRA2A—Class A/1 (Rhodopsin-like receptors)—HTR1A—stomach cancer	0.000297	0.00159	CbGpPWpGaD
Methyldopa—COMT—Metabolism—SREBF2—stomach cancer	0.000289	0.00155	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling by GPCR—KISS1R—stomach cancer	0.000287	0.00154	CbGpPWpGaD
Methyldopa—ADRA2A—Class A/1 (Rhodopsin-like receptors)—ANXA1—stomach cancer	0.000287	0.00154	CbGpPWpGaD
Methyldopa—COMT—Transmission across Chemical Synapses—MAPK1—stomach cancer	0.000286	0.00153	CbGpPWpGaD
Methyldopa—COMT—Metabolism—RORA—stomach cancer	0.000286	0.00153	CbGpPWpGaD
Methyldopa—DDC—Metabolism—ALOX5—stomach cancer	0.000281	0.0015	CbGpPWpGaD
Methyldopa—ADRA2A—Class A/1 (Rhodopsin-like receptors)—ADRB1—stomach cancer	0.000278	0.00149	CbGpPWpGaD
Methyldopa—DDC—Metabolism—DPYD—stomach cancer	0.000276	0.00148	CbGpPWpGaD
Methyldopa—DDC—Circadian rythm related genes—TP53—stomach cancer	0.000269	0.00144	CbGpPWpGaD
Methyldopa—COMT—Metabolism—ALDOB—stomach cancer	0.000268	0.00144	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—GMPR2—stomach cancer	0.000267	0.00143	CbGpPWpGaD
Methyldopa—ADRA2A—Hemostasis—FGG—stomach cancer	0.000263	0.00141	CbGpPWpGaD
Methyldopa—ADRA2A—GPCRs, Class A Rhodopsin-like—ADRB2—stomach cancer	0.000263	0.00141	CbGpPWpGaD
Methyldopa—ADRA2A—Hemostasis—THBD—stomach cancer	0.000258	0.00138	CbGpPWpGaD
Methyldopa—SLC15A1—Transmembrane transport of small molecules—HMOX1—stomach cancer	0.000257	0.00138	CbGpPWpGaD
Methyldopa—ADRA2A—Platelet activation, signaling and aggregation—FYN—stomach cancer	0.000257	0.00138	CbGpPWpGaD
Methyldopa—COMT—Metabolism—ALOX5—stomach cancer	0.000249	0.00134	CbGpPWpGaD
Methyldopa—DDC—Circadian rythm related genes—IL6—stomach cancer	0.000246	0.00132	CbGpPWpGaD
Methyldopa—COMT—Metabolism—DPYD—stomach cancer	0.000245	0.00131	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—IDH3B—stomach cancer	0.000245	0.00131	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—SUCLG1—stomach cancer	0.000245	0.00131	CbGpPWpGaD
Methyldopa—DDC—Metabolism—GSTT1—stomach cancer	0.000244	0.00131	CbGpPWpGaD
Methyldopa—DDC—Metabolism—CYP2A6—stomach cancer	0.000241	0.00129	CbGpPWpGaD
Methyldopa—ADRA2A—Hemostasis—PPIA—stomach cancer	0.000238	0.00128	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR ligand binding—AGTR2—stomach cancer	0.000235	0.00126	CbGpPWpGaD
Methyldopa—DDC—Metabolism—AKR1C3—stomach cancer	0.000235	0.00126	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR ligand binding—F2R—stomach cancer	0.000232	0.00124	CbGpPWpGaD
Methyldopa—ADRA2A—Hemostasis—SERPINA1—stomach cancer	0.00023	0.00123	CbGpPWpGaD
Methyldopa—COMT—Transmission across Chemical Synapses—HRAS—stomach cancer	0.00023	0.00123	CbGpPWpGaD
Methyldopa—DDC—Metabolism—ENO1—stomach cancer	0.000229	0.00123	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR downstream signaling—HRH4—stomach cancer	0.000228	0.00122	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—NDUFV1—stomach cancer	0.000227	0.00122	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—NDUFS1—stomach cancer	0.000227	0.00122	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR ligand binding—HTR1A—stomach cancer	0.000226	0.00121	CbGpPWpGaD
Methyldopa—ADRA2A—Class A/1 (Rhodopsin-like receptors)—ADRB2—stomach cancer	0.000225	0.00121	CbGpPWpGaD
Methyldopa—COMT—Neuronal System—MAPK1—stomach cancer	0.000219	0.00117	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR ligand binding—ANXA1—stomach cancer	0.000218	0.00117	CbGpPWpGaD
Methyldopa—COMT—Metabolism—GSTT1—stomach cancer	0.000217	0.00116	CbGpPWpGaD
Methyldopa—COMT—Metabolism—CYP2A6—stomach cancer	0.000214	0.00115	CbGpPWpGaD
Methyldopa—ADRA2A—Platelet activation, signaling and aggregation—APOA1—stomach cancer	0.000213	0.00114	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR ligand binding—ADRB1—stomach cancer	0.000211	0.00113	CbGpPWpGaD
Methyldopa—COMT—Metabolism—AKR1C3—stomach cancer	0.000208	0.00112	CbGpPWpGaD
Methyldopa—ADRA2A—Hemostasis—SPARC—stomach cancer	0.000208	0.00111	CbGpPWpGaD
Methyldopa—ADRA2A—Hemostasis—F2R—stomach cancer	0.000208	0.00111	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling by GPCR—HRH4—stomach cancer	0.000207	0.00111	CbGpPWpGaD
Methyldopa—ADRA2A—Platelet activation, signaling and aggregation—PRKCB—stomach cancer	0.000204	0.00109	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR downstream signaling—KISS1—stomach cancer	0.000204	0.00109	CbGpPWpGaD
Methyldopa—ADRA2A—Hemostasis—IRF1—stomach cancer	0.000203	0.00109	CbGpPWpGaD
Methyldopa—COMT—Metabolism—ENO1—stomach cancer	0.000203	0.00109	CbGpPWpGaD
Methyldopa—DDC—Metabolism—CD44—stomach cancer	0.000203	0.00109	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—BLVRB—stomach cancer	0.000203	0.00109	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—PGLS—stomach cancer	0.000203	0.00109	CbGpPWpGaD
Methyldopa—SLC15A1—Transmembrane transport of small molecules—APOA1—stomach cancer	0.000195	0.00104	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—PPAP2A—stomach cancer	0.000193	0.00104	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling by GPCR—KISS1—stomach cancer	0.000185	0.000991	CbGpPWpGaD
Methyldopa—COMT—Metabolism—CD44—stomach cancer	0.00018	0.000965	CbGpPWpGaD
Methyldopa—ADRA2A—Hemostasis—CD44—stomach cancer	0.000177	0.000946	CbGpPWpGaD
Methyldopa—COMT—Neuronal System—HRAS—stomach cancer	0.000176	0.000943	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR downstream signaling—RGS2—stomach cancer	0.000175	0.000938	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR downstream signaling—GAST—stomach cancer	0.000175	0.000938	CbGpPWpGaD
Methyldopa—DDC—Metabolism—PPP2R1A—stomach cancer	0.000172	0.000924	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—CA1—stomach cancer	0.000172	0.000924	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—FBP1—stomach cancer	0.000172	0.000924	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—NDUFA2—stomach cancer	0.000172	0.000924	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—CKB—stomach cancer	0.000172	0.000924	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR ligand binding—ADRB2—stomach cancer	0.000171	0.000918	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—GLI3—stomach cancer	0.000169	0.000909	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—KISS1R—stomach cancer	0.000169	0.000909	CbGpPWpGaD
Methyldopa—ADRA2A—Platelet activation, signaling and aggregation—SERPINE1—stomach cancer	0.000169	0.000908	CbGpPWpGaD
Methyldopa—DDC—Metabolism—GSTP1—stomach cancer	0.000169	0.000907	CbGpPWpGaD
Methyldopa—ADRA2A—Platelet activation, signaling and aggregation—ALB—stomach cancer	0.000169	0.000907	CbGpPWpGaD
Methyldopa—DDC—Metabolism—HMOX1—stomach cancer	0.000167	0.000894	CbGpPWpGaD
Methyldopa—ADRA2A—Platelet activation, signaling and aggregation—RHOA—stomach cancer	0.000163	0.000876	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—PLIN2—stomach cancer	0.000162	0.000869	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—RBP1—stomach cancer	0.000162	0.000867	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling by GPCR—RGS2—stomach cancer	0.000159	0.000852	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling by GPCR—GAST—stomach cancer	0.000159	0.000852	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—CA2—stomach cancer	0.000158	0.000845	CbGpPWpGaD
Methyldopa—DDC—Metabolism—TYMS—stomach cancer	0.000157	0.000843	CbGpPWpGaD
Methyldopa—DDC—Metabolism—GSTM1—stomach cancer	0.000155	0.000833	CbGpPWpGaD
Methyldopa—SLC15A1—Transmembrane transport of small molecules—ALB—stomach cancer	0.000154	0.000827	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—NT5E—stomach cancer	0.000154	0.000823	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—PGAM1—stomach cancer	0.000154	0.000823	CbGpPWpGaD
Methyldopa—COMT—Metabolism—PPP2R1A—stomach cancer	0.000153	0.000821	CbGpPWpGaD
Methyldopa—COMT—Metabolism—GSTP1—stomach cancer	0.00015	0.000805	CbGpPWpGaD
Methyldopa—ADRA2A—Hemostasis—PPP2R1A—stomach cancer	0.00015	0.000805	CbGpPWpGaD
Methyldopa—COMT—Metabolism—HMOX1—stomach cancer	0.000148	0.000794	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—ALDH7A1—stomach cancer	0.000147	0.000786	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—PLCE1—stomach cancer	0.000147	0.000786	CbGpPWpGaD
Methyldopa—DDC—Metabolism—ERCC2—stomach cancer	0.000146	0.000783	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—UMPS—stomach cancer	0.000141	0.000753	CbGpPWpGaD
Methyldopa—COMT—Metabolism—TYMS—stomach cancer	0.00014	0.000748	CbGpPWpGaD
Methyldopa—COMT—Metabolism—GSTM1—stomach cancer	0.000138	0.00074	CbGpPWpGaD
Methyldopa—DDC—Metabolism—MTHFR—stomach cancer	0.000137	0.000736	CbGpPWpGaD
Methyldopa—ADRA2A—G alpha (i) signalling events—CXCL8—stomach cancer	0.000137	0.000732	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR downstream signaling—AGTR2—stomach cancer	0.000133	0.000711	CbGpPWpGaD
Methyldopa—ADRA2A—Hemostasis—FYN—stomach cancer	0.000132	0.000709	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—WWOX—stomach cancer	0.000132	0.000707	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR downstream signaling—F2R—stomach cancer	0.000131	0.000703	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—PDHA1—stomach cancer	0.000131	0.0007	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—ECHS1—stomach cancer	0.000131	0.0007	CbGpPWpGaD
Methyldopa—COMT—Metabolism—ERCC2—stomach cancer	0.00013	0.000696	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR downstream signaling—HTR1A—stomach cancer	0.000128	0.000685	CbGpPWpGaD
Methyldopa—DDC—Metabolism—CAV1—stomach cancer	0.000127	0.000679	CbGpPWpGaD
Methyldopa—DDC—Metabolism—APOA1—stomach cancer	0.000126	0.000678	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR downstream signaling—ANXA1—stomach cancer	0.000123	0.000661	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—FADS1—stomach cancer	0.000123	0.000658	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—TYMP—stomach cancer	0.000123	0.000658	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—HRH4—stomach cancer	0.000123	0.000657	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—WIF1—stomach cancer	0.000123	0.000657	CbGpPWpGaD
Methyldopa—COMT—Metabolism—MTHFR—stomach cancer	0.000122	0.000654	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling by GPCR—AGTR2—stomach cancer	0.00012	0.000646	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR downstream signaling—ADRB1—stomach cancer	0.000119	0.00064	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling by GPCR—F2R—stomach cancer	0.000119	0.000639	CbGpPWpGaD
Methyldopa—ADRA2A—Platelet activation, signaling and aggregation—VEGFA—stomach cancer	0.000117	0.000625	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling by GPCR—HTR1A—stomach cancer	0.000116	0.000622	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—SREBF2—stomach cancer	0.000115	0.000616	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—RORA—stomach cancer	0.000114	0.000609	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—PRKAB1—stomach cancer	0.000113	0.000606	CbGpPWpGaD
Methyldopa—ADRA2A—Hemostasis—PLAU—stomach cancer	0.000113	0.000605	CbGpPWpGaD
Methyldopa—COMT—Metabolism—CAV1—stomach cancer	0.000113	0.000603	CbGpPWpGaD
Methyldopa—COMT—Metabolism—APOA1—stomach cancer	0.000112	0.000602	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling by GPCR—ANXA1—stomach cancer	0.000112	0.0006	CbGpPWpGaD
Methyldopa—DDC—Metabolism—PPARG—stomach cancer	0.000111	0.000597	CbGpPWpGaD
Methyldopa—ADRA2A—Hemostasis—CAV1—stomach cancer	0.00011	0.000591	CbGpPWpGaD
Methyldopa—ADRA2A—Platelet activation, signaling and aggregation—MAPK3—stomach cancer	0.00011	0.000591	CbGpPWpGaD
Methyldopa—ADRA2A—Hemostasis—APOA1—stomach cancer	0.00011	0.00059	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—KISS1—stomach cancer	0.000109	0.000585	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—RNF43—stomach cancer	0.000109	0.000585	CbGpPWpGaD
Methyldopa—ADRA2A—Class A/1 (Rhodopsin-like receptors)—CXCL8—stomach cancer	0.000109	0.000582	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling by GPCR—ADRB1—stomach cancer	0.000108	0.000582	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—ALDOB—stomach cancer	0.000106	0.000571	CbGpPWpGaD
Methyldopa—ADRA2A—Hemostasis—PRKCB—stomach cancer	0.000105	0.000563	CbGpPWpGaD
Methyldopa—ADRA2A—Platelet activation, signaling and aggregation—MAPK1—stomach cancer	0.000105	0.000562	CbGpPWpGaD
Methyldopa—DDC—Metabolism—ALB—stomach cancer	0.0001	0.000537	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—ALOX5—stomach cancer	9.9e-05	0.000531	CbGpPWpGaD
Methyldopa—COMT—Metabolism—PPARG—stomach cancer	9.89e-05	0.00053	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—DPYD—stomach cancer	9.74e-05	0.000522	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—FST—stomach cancer	9.74e-05	0.000522	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR downstream signaling—ADRB2—stomach cancer	9.68e-05	0.000519	CbGpPWpGaD
Methyldopa—DDC—Metabolism—NOS3—stomach cancer	9.58e-05	0.000514	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling by GPCR—HBEGF—stomach cancer	9.52e-05	0.000511	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—RGS2—stomach cancer	9.39e-05	0.000503	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—GAST—stomach cancer	9.39e-05	0.000503	CbGpPWpGaD
Methyldopa—ADRA2A—Platelet activation, signaling and aggregation—PIK3CA—stomach cancer	9.1e-05	0.000488	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—FGG—stomach cancer	8.9e-05	0.000477	CbGpPWpGaD
Methyldopa—COMT—Metabolism—ALB—stomach cancer	8.89e-05	0.000477	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling by GPCR—ADRB2—stomach cancer	8.79e-05	0.000471	CbGpPWpGaD
Methyldopa—DDC—Metabolism—PTGS2—stomach cancer	8.76e-05	0.00047	CbGpPWpGaD
Methyldopa—ADRA2A—Hemostasis—SERPINE1—stomach cancer	8.74e-05	0.000468	CbGpPWpGaD
Methyldopa—ADRA2A—Hemostasis—ALB—stomach cancer	8.72e-05	0.000467	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling by GPCR—PPP2R1A—stomach cancer	8.61e-05	0.000462	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—GSTT1—stomach cancer	8.61e-05	0.000462	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—PRKAA1—stomach cancer	8.57e-05	0.000459	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—CYP2A6—stomach cancer	8.51e-05	0.000456	CbGpPWpGaD
Methyldopa—COMT—Metabolism—NOS3—stomach cancer	8.51e-05	0.000456	CbGpPWpGaD
Methyldopa—ADRA2A—Hemostasis—RHOA—stomach cancer	8.43e-05	0.000452	CbGpPWpGaD
Methyldopa—ADRA2A—Hemostasis—NOS3—stomach cancer	8.34e-05	0.000447	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—AKR1C3—stomach cancer	8.28e-05	0.000444	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—RBP4—stomach cancer	8.28e-05	0.000444	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR ligand binding—CXCL8—stomach cancer	8.27e-05	0.000443	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—ENO1—stomach cancer	8.07e-05	0.000433	CbGpPWpGaD
Methyldopa—COMT—Metabolism—PTGS2—stomach cancer	7.78e-05	0.000417	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—CD44—stomach cancer	7.16e-05	0.000384	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—HSPB1—stomach cancer	7.12e-05	0.000382	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—AGTR2—stomach cancer	7.12e-05	0.000382	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—F2R—stomach cancer	7.04e-05	0.000377	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—BMP2—stomach cancer	7.04e-05	0.000377	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—AKR1C3—stomach cancer	6.92e-05	0.000371	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—HTR1A—stomach cancer	6.85e-05	0.000367	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR downstream signaling—PRKCB—stomach cancer	6.63e-05	0.000356	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—ANXA1—stomach cancer	6.62e-05	0.000355	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—ADRB1—stomach cancer	6.41e-05	0.000344	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—RPS6—stomach cancer	6.12e-05	0.000328	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—PPP2R1A—stomach cancer	6.09e-05	0.000326	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling by GPCR—PRKCB—stomach cancer	6.02e-05	0.000323	CbGpPWpGaD
Methyldopa—ADRA2A—Hemostasis—VEGFA—stomach cancer	6.01e-05	0.000322	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling by GPCR—IL6ST—stomach cancer	6e-05	0.000322	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—GSTP1—stomach cancer	5.97e-05	0.00032	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—HMOX1—stomach cancer	5.89e-05	0.000316	CbGpPWpGaD
Methyldopa—ADRA2A—Hemostasis—MAPK3—stomach cancer	5.68e-05	0.000305	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—HBEGF—stomach cancer	5.63e-05	0.000302	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—TYMS—stomach cancer	5.55e-05	0.000297	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—GSTM1—stomach cancer	5.49e-05	0.000294	CbGpPWpGaD
Methyldopa—ADRA2A—Hemostasis—MAPK1—stomach cancer	5.41e-05	0.00029	CbGpPWpGaD
Methyldopa—DDC—Metabolism—PIK3CA—stomach cancer	5.39e-05	0.000289	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling by GPCR—IL6R—stomach cancer	5.35e-05	0.000287	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR downstream signaling—RHOA—stomach cancer	5.33e-05	0.000285	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—ADRB2—stomach cancer	5.19e-05	0.000278	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—ERCC2—stomach cancer	5.16e-05	0.000276	CbGpPWpGaD
Methyldopa—ADRA2A—Hemostasis—KRAS—stomach cancer	5.11e-05	0.000274	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—PPP2R1A—stomach cancer	5.09e-05	0.000273	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—MTHFR—stomach cancer	4.85e-05	0.00026	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling by GPCR—RHOA—stomach cancer	4.84e-05	0.000259	CbGpPWpGaD
Methyldopa—COMT—Metabolism—PIK3CA—stomach cancer	4.79e-05	0.000257	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—SMAD4—stomach cancer	4.72e-05	0.000253	CbGpPWpGaD
Methyldopa—ADRA2A—Hemostasis—PIK3CA—stomach cancer	4.69e-05	0.000252	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR downstream signaling—CXCL8—stomach cancer	4.68e-05	0.000251	CbGpPWpGaD
Methyldopa—ADRA2A—Hemostasis—TP53—stomach cancer	4.54e-05	0.000243	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—FYN—stomach cancer	4.49e-05	0.00024	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—CAV1—stomach cancer	4.47e-05	0.00024	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—APOA1—stomach cancer	4.46e-05	0.000239	CbGpPWpGaD
Methyldopa—ADRA2A—Hemostasis—HRAS—stomach cancer	4.34e-05	0.000233	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling by GPCR—CXCL8—stomach cancer	4.25e-05	0.000228	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—FGFR2—stomach cancer	4.21e-05	0.000226	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—PPARG—stomach cancer	3.93e-05	0.000211	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—IRS2—stomach cancer	3.86e-05	0.000207	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—CAV1—stomach cancer	3.74e-05	0.0002	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—APOA1—stomach cancer	3.73e-05	0.0002	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—PRKCB—stomach cancer	3.56e-05	0.000191	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—IL6ST—stomach cancer	3.54e-05	0.00019	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—ALB—stomach cancer	3.53e-05	0.000189	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—APC—stomach cancer	3.41e-05	0.000183	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—NOS3—stomach cancer	3.38e-05	0.000181	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling by GPCR—MAPK3—stomach cancer	3.26e-05	0.000175	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—IL6R—stomach cancer	3.16e-05	0.00017	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling by GPCR—MAPK1—stomach cancer	3.1e-05	0.000166	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling by GPCR—EGFR—stomach cancer	3.1e-05	0.000166	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—PTGS2—stomach cancer	3.09e-05	0.000166	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR downstream signaling—PIK3CA—stomach cancer	2.97e-05	0.000159	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—SERPINE1—stomach cancer	2.96e-05	0.000159	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling by GPCR—KRAS—stomach cancer	2.93e-05	0.000157	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—RHOA—stomach cancer	2.86e-05	0.000153	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—NOS3—stomach cancer	2.83e-05	0.000152	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling by GPCR—PIK3CA—stomach cancer	2.69e-05	0.000144	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—ERBB2—stomach cancer	2.64e-05	0.000142	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—CXCL8—stomach cancer	2.51e-05	0.000134	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling by GPCR—HRAS—stomach cancer	2.49e-05	0.000134	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—CDKN1B—stomach cancer	2.45e-05	0.000131	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling by GPCR—IL6—stomach cancer	2.38e-05	0.000128	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—CCND1—stomach cancer	2.34e-05	0.000125	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—JUN—stomach cancer	2.33e-05	0.000125	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—MMP9—stomach cancer	2.27e-05	0.000122	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—CDKN1A—stomach cancer	2.26e-05	0.000121	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—MAPK8—stomach cancer	2.21e-05	0.000118	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—VEGFA—stomach cancer	2.04e-05	0.000109	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—STAT3—stomach cancer	2.02e-05	0.000108	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—MAPK3—stomach cancer	1.93e-05	0.000103	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—PIK3CA—stomach cancer	1.9e-05	0.000102	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—MYC—stomach cancer	1.87e-05	0.0001	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—MAPK1—stomach cancer	1.83e-05	9.83e-05	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—EGFR—stomach cancer	1.83e-05	9.83e-05	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—KRAS—stomach cancer	1.73e-05	9.28e-05	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—PIK3CA—stomach cancer	1.59e-05	8.53e-05	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—TP53—stomach cancer	1.54e-05	8.25e-05	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—HRAS—stomach cancer	1.47e-05	7.89e-05	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—IL6—stomach cancer	1.41e-05	7.55e-05	CbGpPWpGaD
